Fluent biosciences RNA reagent kits (ambis 2229743)
Closed Pre-Solicitation Posted
- Solicitation number
- NOI-NIAID-24-2229743
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Fluent Biosciences Inc. to procure PIPseq and Fluent brand reagents for ongoing research. The NIH is seeking a variety of reagent kits, including PIPseq V T20 3' Single Cell RNA Kit Bundles, PIPseq V T2 3' Single Cell RNA Kit Bundles, Fluent V Nuclei Isolation Kits, and PIPseq V Universal Upgrade Starter Equipment Kits. The total quantity across these items is 17. The contract will be awarded as a firm-fixed price type, with an estimated 30-day delivery after receipt and acceptance of the award.
This procurement has no set-aside designations. The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1), indicating that there is only one responsible source and no other supply or service will satisfy the agency's requirements. The estimated delivery location is the NIH/NIAID/Neuroimmunological Diseases Section in Bethesda, Maryland. Interested parties may submit capability statements by email to the contracting officer by 4:00 pm EST on August 9, 2024.
Notice text
This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Fluent Biosciences Inc, 150 Coolidge Avenue, Watertown, MA 02472-2815, to procure PIPseq and Fluent brand reagents for ongoing research.
The National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. Within NIAID, the Neuroimmunological Diseases Section (NDS), mission is to understand, diagnose, prognosticate, and cure neuroimmunological diseases. Through understanding of the mechanisms that participate in central nervous system (CNS) injury and those that have neuroprotective functions, the NDS aim is to develop effective therapies for neuroimmunological diseases.
Description of Need:
- PIPseq V T20 3' Single Cell RNA Kit Bundle, Catalog # FB0005386, Qty - 7
- PIPseq V T2 3' Single Cell RNA Kit Bundle, Catalog # FB0005384, Qty -2
- Fluent V Nuclei Isolation Kit, 4 rxn, Catalog # FB0005375, Qty - 7
- PIPseq V Universal Upgrade Starter Equipment Kit, Catalog # FB0005427, Qty – 1
- Shipping and Handling, Qty - 1
Only one award will be made as a result of this solicitation. This will be awarded as a firm-fixed price type of contract.
Delivery: Estimate delivery has a 30 days ARO after receipt and acceptance of award.
Delivery Location: NIH/NIAID/NDS, 10 Center Drive, Bethesda, MD 20892.
The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A SOLICITATION FOR COMPETITIVE QUOTATIONS. All responsible sources that could provide the required services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-24-2229743) to Rita Davis at rita.davis@nih.gov , by 4:00pm eastern standard time August 9, 2024. All responses received by the closing date of this synopsis will be considered by the Government. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity